Benitec Biopharma Inc. (BNTC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 423.65M |
| Enterprise Value | 326.75M |
| P/E Ratio | -10.98 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 753.2 |
| Price/Book Ratio | 3.28 |
| Enterprise/Revenue | 422.47 |
| Enterprise/EBITDA | -4.39 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -87.92 |
| Operating Margin | -97.01 |
| Return On Assets | -0.26 |
| Return On Equity | -0.35 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | -396,000 |
| EBITDA | -41.37M |
| Net Income | -37.92M |
| Diluted EPS | -1.05 |
| Total Cash | 184.76M |
| Total Cash/Share | 3.74 |
| Total Debt | 876,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 56.82 |
| Book Value Per Share | 3.71 |
| 52-Week Change | -12.8 |
| 52-Week High | 16.76 |
| 52-Week Low | 9.85 |
| Moving Average 50 Days | 12.66 |
| Moving Average 200 Days | 12.09 |
| Average Volume | 141,662 |
| Shares Outstanding | 34.35M |
| % Held by Institutions | 67.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:17 |
| Last Split Date | July 26, 2023 |